We hope that you’ll never need to worry about whether a diagnosis and proposed treatment for serious illness is correct. Nonetheless, whenever we are faced with a serious illness, especially one requiring irreversible treatment options, it is perfectly natural to want to be absolutely certain that the diagnosis is 100% accurate. Obtaining a second opinion is the best way to ensure that, and Cinagi has made it convenient and cost-free by incorporating the international Medical Second Opinion service into all our gap cover policies.

The Medical Second Opinion service is delivered by our American business partner, Mediguide International LLC, and ensures that you can access one of over 100 World Leading Medical Research Centres (WLMRC) for a comprehensive review of your local diagnosis. This ensures that you can access the world’s leading medical minds to ensure that you have the correct diagnosis and, importantly, the optimal treatment plan.

Leading medical research centres such as Harvard Medical School, Cleveland Clinic, King’s College Hospital and Boston Children’s Hospital are just some of the centres on our international panel.

This distinctive approach joins together a number of medical specialists from various clinical specialities at the WLMRC, who are at the cutting edge of medical science globally. This approach joins these specialist skills to provide the most comprehensive clinical review possible of your medical records and diagnosis.

Mediguide is recognised as the leader in their field, serving millions of members worldwide in more than 50 countries.

Why should I obtain a Medical Second Opinion?

A 2012 study published by researchers in the British Medical Journal showed that patients with confirmed serious medical conditions that were sent anonymously into medical practices were, on average, misdiagnosed about 14% of the time. In addition to diagnosis errors, a Harvard Medical School study showed that their scientists performing Medical Second Opinions enhanced the original treatment plan in 90% of cases for certain medical conditions.

Even when a MSO confirms that your original diagnosis is 100% accurate, substantial confidence is gained that you are on the right treatment plan. And since we have automatically incorporated MSO for free into our offering, there is no cost barrier to you in finding that peace of mind.

If you would like to read more about misdiagnosis, click here.

A Case Study – Medical Second Opinion

In 2016, 35 year-old Henry Cullen*, already being treated for hypertension, discovered blood in his urine. After consulting his specialist physician, Henry underwent a CT scan, an MRI scan, pathology tests and a fine needle biopsy of his right kidney. He was subsequently diagnosed with malignant carcinoma – a cancerous tumour on his right kidney. The proposed treatment plan was the surgical removal of the entire kidney, followed by several months of chemotherapy and radiation treatment.

Henry remembered that his health insurance plan included the Medical Second Opinion service and he decided to undertake a review of his diagnosis. With Mediguide’s assistance, Henry selected Cleveland Clinic in Ohio to undertake the diagnosis review and in co-operation with his physicians and other medical providers, Mediguide collated his complete medical records and securely uploaded these to Dr Novick’s specialist urology team at Cleveland Clinic.

Dr Novick and his team undertook the diagnosis review by reassessing the CT and MRI scans, the pathology reports, the needle biopsy results and his general medical file and then compared these against their substantial experience and extensive clinical database. After completing this comprehensive review and database comparison, Dr Novick and his team concluded that the tumour was very unlikely to be malignant, with a 90%+ probability that it was benign. This was based on the outcome of ±1,600 other clinically similar cases in Cleveland Clinic’s database that they had successfully reviewed.

Henry’s new treatment plan, proposed by Dr Novick and his team, was to target removal of the tumour rather than the whole kidney. Since the tumour was growing on the kidney, this revised treatment plan still required a partial excision of approximately half the kidney but it had the distinct advantage of preserving the unaffected half.

Henry proceeded with the less radical surgery and the subsequent diagnostic tests showed that the tumour was indeed benign. He was hugely relieved. Not only did Henry not have cancer – which would have required months of chemotherapy and radiation treatment – he retained the unaffected half of his kidney which was still functioning normally.

The clinical outcome for Henry was significantly improved! Had he proceeded with the original treatment, not only would he have unnecessarily lost his entire kidney, he would then also have had to deal with far more complex management of his ongoing hypertension.

* – a pseudonym was used to protect the patient’s identity.